Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2017Journal of Medical Economics

Healthcare resource utilization and costs for patients with pulmonary arterial hypertension: real-world documentation of functional class

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Is higher WHO Functional Class associated with increased healthcare resource utilization and costs in patients with pulmonary arterial hypertension?

Population

Patients with a prescription for an FDA-approved treatment for pulmonary arterial hypertension and a medical…

Comparison

WHO Functional Class IV (severe disease) vs Other WHO Functional Class sub-groups

Design

Cohort

Authors

RDRobert DufourMyovant Sciences (United States)JPJanis PruettSumitomo Dainippon Pharma (United States)NHNan HuBristol-Myers Squibb (United States)

Discussion

Loading...

Member takes

Implication

Supports economic modeling in PAH; leaves open need for prospective validation before guiding decisions.

Structured PICO

Is higher WHO Functional Class associated with increased healthcare resource utilization and costs in patients with pulmonary arterial hypertension?

P
Population
Patients with a prescription for an FDA-approved treatment for pulmonary arterial hypertension and a medical claim indicating chronic pulmonary heart disease or right heart catheterization identified from an administrative claims database
I
Intervention
WHO Functional Class IV (severe disease)
C
Comparator
Other WHO Functional Class sub-groups
O
Outcome
Healthcare resource utilization and costs (accounted in 2014 US dollars)

In patients with pulmonary arterial hypertension, greater disease severity as indicated by WHO Functional Class IV is associated with significantly higher healthcare resource utilization and costs.

Cite This Study

Dufour et al. (2017) studied this question.

synapsesocial.com/papers/6a713037ac440176ef29deadhttps://doi.org/10.1080/13696998.2017.1363049
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Optimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment course2014 · 24 citations
  2. 2Challenges in the diagnosis and treatment of pulmonary arterial hypertension2012 · 74 citations
  3. 3Cardiac Catheterization in Pulmonary Arterial Hypertension: An Updated Guide to Proper Use2005 · 17 citations
  4. 4Diagnosis and Assessment of Pulmonary Arterial Hypertension2009 · 1,140 citations
  5. 5Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)2009 · 3,869 citations